BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34064748)

  • 1. Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.
    Idlas P; Lepeltier E; Jaouen G; Passirani C
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure.
    Idlas P; Lepeltier E; Bastiat G; Pigeon P; McGlinchey MJ; Lautram N; Vessières A; Jaouen G; Passirani C
    Langmuir; 2023 Feb; 39(5):1885-1896. PubMed ID: 36693216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
    Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
    Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma.
    Idlas P; Ladaycia A; Némati F; Lepeltier E; Pigeon P; Jaouen G; Decaudin D; Passirani C
    Int J Pharm; 2022 Oct; 626():122164. PubMed ID: 36089209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanocapsules: a new platform for nanomedicine.
    Huynh NT; Passirani C; Saulnier P; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
    Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
    Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
    Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
    Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
    Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
    Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
    Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
    Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
    Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
    Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
    Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
    Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes.
    Vessières A; Quissac E; Lemaire N; Alentorn A; Domeracka P; Pigeon P; Sanson M; Idbaih A; Verreault M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules.
    Lainé AL; Clavreul A; Rousseau A; Tétaud C; Vessieres A; Garcion E; Jaouen G; Aubert L; Guilbert M; Benoit JP; Toillon RA; Passirani C
    Nanomedicine; 2014 Nov; 10(8):1667-77. PubMed ID: 24842766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8
    Topin-Ruiz S; Mellinger A; Lepeltier E; Bourreau C; Fouillet J; Riou J; Jaouen G; Martin L; Passirani C; Clere N
    Int J Pharm; 2021 Jan; 593():120111. PubMed ID: 33246045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.
    Saliou B; Thomas O; Lautram N; Clavreul A; Hureaux J; Urban T; Benoit JP; Lagarce F
    Eur J Pharm Sci; 2013 Oct; 50(2):172-80. PubMed ID: 23831519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides.
    Wang Y; Pigeon P; Top S; McGlinchey MJ; Jaouen G
    Angew Chem Int Ed Engl; 2015 Aug; 54(35):10230-3. PubMed ID: 26179051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.
    Lainé AL; Adriaenssens E; Vessières A; Jaouen G; Corbet C; Desruelles E; Pigeon P; Toillon RA; Passirani C
    Biomaterials; 2013 Sep; 34(28):6949-56. PubMed ID: 23777919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.
    Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI
    Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.